Electrocardiographic evidence of ventricular repolarization remodelling during atrial fibrillation
- PMID: 18094018
- DOI: 10.1093/europace/eum270
Electrocardiographic evidence of ventricular repolarization remodelling during atrial fibrillation
Abstract
Aims: Some atrial fibrillation (AF) patients develop excessive QTc prolongation and torsade de pointes when they take QTc-prolonging antiarrhythmic drugs (class IA/III) immediately after termination of AF. We hypothesized that this is caused by changes in ventricular repolarization during AF. We aimed to establish whether such 'ventricular repolarization remodelling' occurs.
Methods and results: We studied all patients who visited our cardiac emergency room with AF and converted to sinus rhythm (SR) in a 30 months' period. We defined four groups: (i) no antiarrhythmic drugs, electrical cardioversion (n = 30), (ii) no antiarrhythmic drugs, spontaneous AF termination (n = 19), (iii) antiarrhythmic drugs, electrical cardioversion (n = 29), and (iv) antiarrhythmic drugs, spontaneous AF termination (n = 9). We studied QTc duration at SR before AF (SR(baseline)), immediately after termination of AF (SR(postAF)), and at follow-up (SR(followup): > or =7 days after SR(postAF)). Moreover, we studied determinants of QTc prolongation at SR(postAF). We found that, in all groups, QTc at SR(postAF) was significantly and transiently prolonged compared with SR(baseline). Although of limited magnitude on average (approximately 5%), the increase was substantial (approximately 15%) in some individuals. The only independent predictor of the magnitude of QTc prolongation was QTc duration at SR(baseline); this relation had a negative correlation.
Conclusion: AF causes ventricular repolarization remodelling, resulting in QTc prolongation. QTc prolongation is substantial in some patients and may render these patients vulnerable to pro-arrhythmia from class IA/III antiarrhythmic drugs immediately after termination of AF.
Similar articles
-
Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.Int J Cardiol. 2005 Mar 18;99(2):283-7. doi: 10.1016/j.ijcard.2004.01.020. Int J Cardiol. 2005. PMID: 15749188
-
Increase in QT/QTc dispersion after low energy cardioversion of chronic persistent atrial fibrillation.Int J Cardiol. 2004 Jun;95(2-3):245-50. doi: 10.1016/j.ijcard.2003.05.022. Int J Cardiol. 2004. PMID: 15193827
-
Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.Am Heart J. 2005 Nov;150(5):899. doi: 10.1016/j.ahj.2005.07.020. Am Heart J. 2005. PMID: 16290956
-
[Drug and electrical therapy of supraventricular tachyarrhythmias].Z Kardiol. 2000;89 Suppl 3:68-74. Z Kardiol. 2000. PMID: 10810788 Review. German.
-
Mechanisms of pharmacologic cardioversion of atrial fibrillation by Class I drugs.J Cardiovasc Electrophysiol. 1998 Aug;9(8 Suppl):S69-77. J Cardiovasc Electrophysiol. 1998. PMID: 9727679 Review.
Cited by
-
QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation.Front Cardiovasc Med. 2022 Jun 3;9:881446. doi: 10.3389/fcvm.2022.881446. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35722129 Free PMC article.
-
Clinical and Echocardiographic Predictors of Arrhythmias Detected With 24-Hour Holter Electrocardiography Among Hypertensive Heart Failure Patients in Nigeria.Clin Med Insights Cardiol. 2017 Dec 10;11:1179546817746632. doi: 10.1177/1179546817746632. eCollection 2017. Clin Med Insights Cardiol. 2017. PMID: 29270037 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
